Investors are frequently on the lookout for factors that could potentially influence price movements. One major factor that often exerts a significant impact on prices is news. Positive developments in the news can potentially propel stocks to higher levels, particularly when combined with favorable momentum in the desired direction.
Now, let’s delve deeper into four stocks that have recently released noteworthy news:
Epazz Inc. (OTC:EPAZ)
Epazz Inc. is continuing to make significant strides in the world of drone technology, and its recent announcement regarding ZenaDrone’s expansion into Ireland is a testament to its potential for growth. The company’s subsidiary, ZenaDrone, is sending its first batch of ZenaDrone 1000s to Ireland for Drone as a Service (DaaS) operations.
According to the press release, each deployed ZenaDrone 1000 in Ireland has the potential to generate over $100,000 annually, catering to various sectors such as agriculture, public safety, and first-responder systems. Collaborating with Irish farmers, these drones will monitor plant health and contribute to weed control.
Additionally, the drones will be seamlessly integrated into the operations of local police forces and fire departments, enhancing their efficiency in responding to emergencies.
Epazz’s success isn’t limited to Ireland; it has laid a strong foundation in the United States, particularly within the U.S. military. High-ranking U.S. Navy personnel, along with branches like the U.S. Air Force, U.S. Marine Corps, and U.S. Army, have expressed keen interest in Epazz’s drone technology. The U.S. Navy’s decision to choose the ZenaDrone 1000 for critical missions underscores the adaptability and potential impact of these drones within the defense sector. CEO Shaun Passley envisions a substantial portion of the company’s revenue stemming from U.S. government sales.
Epazz has also strategically expanded into Germany, establishing ZenaDroneGmbH, a German corporation that specializes in drone demonstrations. The recent feature of the ZenaDrone 1000 at the AERO General Aviation Convention in Friedrichshafen, Germany, has paved the way for scheduled demonstrations with NATO partner countries, law enforcement departments, and major rail lines in Germany. Epazz’s drones, equipped with advanced safety features and cutting-edge technology, are emerging as valuable assets across various industries.
In addition to its U.S. and European endeavors, Epazz is diversifying its revenue sources by entering markets like Taiwan and Brazil. A strategic partnership with Thunder Tiger, a Taiwanese defense contractor, positions the company to address the demands of the Taiwanese government. In response to strong interest from Brazilian organizations, Epazz has established a facility and infrastructure for ZenaDrone 1000 operations in Brazil.
These recent developments firmly position Epazz Inc. as a prominent player in the dynamic landscape of drone technology. Epazz’s strategic moves in international markets and its growing recognition within the U.S. military present substantial opportunities, making EPAZ a penny stock to watch.
Theralink Technologies (OTC:THER)
In the world of precision medicine and oncology, Theralink Technologies (OTC:THER) is making headlines with its latest announcement. The company, known for its groundbreaking proteomics-based approach to cancer care, has filed a Form S-4 with the Securities and Exchange Commission (SEC) to move forward with its merger with IMAC Holdings, Inc. (NASDAQ:IMAC). This strategic move is set to create an entirely new entity listed on NASDAQ, focused on end-to-end proteomics testing.
Theralink’s proprietary phosphoprotein and protein assay technology have already been a game-changer in the oncology landscape. With a nationally CLIA-certified and CAP-accredited laboratory in Golden, Colorado, Theralink has been at the forefront of precision medicine. Its first assay for advanced breast cancer showcased the power of its approach.
The upcoming merger with IMAC Holdings opens new doors. It signifies a definitive agreement, positioning Theralink and IMAC as proteomics powerhouses. What sets this merger apart is the combined strength of their patent estates, certified laboratories, and reimbursement agreements, including major payors like Medicare.
With regulatory approval anticipated soon, this merger might be finished by the end of the quarter. Investors should keep an eye on upcoming investor calls for deeper insights. Theralink and IMAC’s focus on proteomics testing and their leadership’s ability to execute could create substantial opportunities. While investing always carries risks, Theralink’s strategic moves and the merger’s potential for breakthroughs in cancer care make it an exciting stock to watch.
Sidney Resources Corporation (OTC:SDNR)
Sidney Resources is actively engaged in exploration and development across two historic mining districts in north-central Idaho. The Lucky Ben Project, located within the Warren Mining District, encompasses three patented claims (the Lucky Ben, Lucky Ben Extension, and Hornet properties) totaling 53 acres, along with an additional fourteen unpatented claims totaling 300 acres directly adjacent. In addition to the Lucky Ben Project, the company is also involved in the Walla Walla Project within the Marshall Lake Mining District, situated approximately 10 miles from the Lucky Ben Project. The Walla Walla Project consists of forty-seven lode claims, or 1.61 square miles of a production-ready, proven resource.
The recent announcement from Sidney Resources Corporation pertains to its successful staking of additional claims near the renowned Hornet Patented Claim, which is part of the Lucky Ben Project. These claims, marked as SRL-1 to SRL-6 and SRP-1 for the placer claim, have been registered with the Bureau of Land Management.
During this exploration effort led by geologist Steve Dobson and COO Dan Hally, the company discovered significant ore stockpiles thought to be remnants of historical mining activities, particularly those associated with the Knott and Delaware Veins. Importantly, these stockpiles contain visible gold, a rare occurrence. Florin Labs will conduct ongoing analysis on the company’s estimated significant quantities of high-grade ore.
This discovery is strategically significant as it enhances the potential of the Lucky Ben Project. Lode claims secure mineral rights for vein structures, while placer claims secure mineral rights to surface materials, ensuring the protection of valuable assets.
This development signifies a new phase of exploration and development for Sidney Resources Corporation, promising exciting opportunities for the company and its stakeholders. Investors may want to closely monitor the progress and forthcoming updates related to this significant discovery.
Houston Natural Resources Corp (OTC:HNRC)
Houston Natural Resources Corp. has recently issued a significant update that has investors buzzing with anticipation. The company, known for its diversified energy portfolio, made headlines with its latest announcement.
In this update, HNRC reported impressive financial figures, with appraised asset values at $2.90 per share and 2023 pro forma earnings of $0.08 per share. These numbers reflect robust financial health and set the stage for potential growth.
One of the standout highlights of this update is HNRC’s successful acquisition of Cunningham Energy, LLC, boasting appraised reserves of $352 million. This strategic move solidifies HNRC’s position in the oil and gas industry, promising further expansion.
Additionally, HNRC revealed its acquisition of a 9% interest in the ‘Nugget Trap Placer Mine’ in British Columbia, Canada, a venture with permits and reserves valued at over $500 million. The company also secured a 40% interest in Rhino Energy Pty Ltd., with a reserve report valuing it at $1.3 billion. These acquisitions not only strengthen HNRC’s asset base but also hint at potential future dividends, raising investor interest.
The engagement with an underwriter for a $10 million commitment demonstrates HNRC’s commitment to shareholder value, with plans to list on a major exchange later in 2023. The company is actively exploring additional opportunities in the energy and energy services sectors, signaling its dedication to long-term growth.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.